About

Company description

PCI is an integrated full service provider and a trusted partner to leading companies in the global healthcare industry; we offer unparalleled expertise and experience in taking compounds from the earliest stages of development through to commercial launch, delivering speed to market and commercial success for our customers.

Core services include: Analytical services, formulation development, clinical trial supply, commercial manufacturing and packaging, QP services, supply chain management, storage and distribution. Customers can choose to use us as a complete development partner and benefit from our full range of services or choose any of our core services as a stand-alone offering.

Quick facts

Sales markets Western Europe, Eastern Europe, Middle East, Asia, Australia, North America, Africa, Central/South America
Affiliated categories: Biotechnology and related specialities |Blending |Chemical synthesis/analysis More

Upcoming events

30 apr 2019

CPhI North America 2019

30 April - 2 May 2019 Chicago, USA Visit us at stand 802 Book a meeting See our Exhibitor Profile   See full Exhibitor List
5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany Visit us at stand 121D10 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

9 oct 2018

CPhI Worldwide 2018

9 - 11 October 2018 Madrid, Spain We were at stand 3F10 See our Exhibitor Profile   See full Exhibitor List
24 apr 2018

CPhI North America 2018

24-26 April, 2018 Philadelphia, USA We were at stand 601 See our Exhibitor Profile   See full Exhibitor List
18 apr 2018

CPhI Japan 2018

18 - 20 April 2018 Tokyo, Japan We were at stand T-04 See our Exhibitor Profile   See full Exhibitor List

News about PCI Pharma Services

Rockford Site Expansion to Support Growth and Flexibility

6 Mar 2019

Rockford Site Expansion to Support Growth and Flexibility

PCI is pleased to announce the expansion of our Clinical site at Rockford, IL. Construction of the expanded Clinical Services facility began on November 12, 2018. The site is one of two US-based PCI locations supporting investigational medicinal products, complementing facilities in the UK, Europe and Australia.

Read more

6 Mar 2019

$20 Million Expansion of Biotech Technologies

PCI is pleased to announce a momentous investment in support of biologic medicines and advanced injectable delivery forms, totaling more than $20 million. We will add expanded Biotech clinical and commercial packaging and release testing capability at our Center of Excellence in Philadelphia.

Read more

6 Mar 2019

Bottling Line Expansion to Support Customer Needs

PCI is pleased to announce the expansion of the bottling line capacity at our Commercial Packaging site in Rockford, IL. Construction of the additional packaging suites began in March 2018 to add considerable footprint for primary and secondary packaging operations.

Read more